Skip to main content
Clinical Trials/NCT01407653
NCT01407653CompletedNot Applicable

Evaluation of the Analgesic Effect of a Prototype Device of Virtual Reality in a Population of Patients With Chronic Low Back Pain. A Randomized Controlled Trial Using a Modified ZELEN Method

Assistance Publique - Hôpitaux de Paris1 site in 1 country122 target enrollmentStarted: June 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
122
Locations
1
Primary Endpoint
Low back pain in the last 48 hours

Study Overview

Brief Summary

Chronic low back pain and sciatica in adults represent a major medical and economic problem. During the chronic back pain (persisting continuously over 3 months), therapeutic responses to conventional pharmacologic type are often ineffective and the impact of pain is often heavy in terms of disability, social and professional avulsion and loss of quality of life. This failure has led in recent years to propose innovative strategies such as application of relaxation therapy techniques. An example is a virtual reality which is a technology to immerse someone in a 3D virtual environment. Our hypothesis is that the hypnotic suggestion combined with virtual reality can be effective on chronic pain. The main purpose is to measure the impact on the intensity of pain at 4 months after using of a new method for virtual environment, mimicking the colors from low to high frequencies (World Patent Filed, WO2007/057601) in patients with chronic disabling low back pain and sciatica resistant to therapeutic drugs.

Detailed Description

Secondary objectives:

  • Quantifying the effects in terms of disability associated with chronic pain
  • Quantifying the effects on the cognitive (affect, anxiety, depression).
  • Study the correlation between pain and oxidative stress.

Methods :a controlled, randomized single-center prospective trial, according to a ZELEN modified scheme

Intervention treatment : Pain treatment by a process of Virtual Reality 3D. The intervention protocol consists of 3 sessions of immersion in a 3D environment of 17 minutes per week for 4 consecutive weeks.

Conducting the study: an inclusion visit, then the intervention protocol for patients in the arm "Virtual Reality" during 4 weeks, and then a monthly follow-up visit for 4 months.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •More than 18 and less than 60 years (inclusive)
  • •Chronic low back pain or chronic sciatica (between 3 months and 1 year of the current episode), without neurological deficit (low back pain more important than sciatica), common spinal origin, resistant to medical therapy, and the numerical pain scale > 30/100
  • •Written informed consent
  • •Membership or beneficiary of an insurance

Exclusion Criteria

  • •Low back pain related to a spinal infectious disease, inflammatory, neoplasia, osteodystrophic, malformative and traumatic.
  • •Deficit sciatica (motor weakness and / or sensory)
  • •Low back pain secondary to failure of spinal intervention.
  • •Co-existence of pain of another etiology.
  • •Seizures.
  • •Psychiatric disorder, uncontrolled.
  • •Visual disturbances (significant decrease in visual acuity without correction possibility, problems with re-cognition of color, visual field loss).
  • •Inclusion in another trial to evaluate new ways of treating pain
  • •Sick leave over 1 year
  • •Pregnant women
  • •Inability to give informed consent

Arms & Interventions

virtual reality

Experimental

Intervention: Virtual reality (Procedure)

usual care

Other

Intervention: Usual care (Procedure)

Outcomes

Primary Outcomes

Low back pain in the last 48 hours

Time Frame: 4 months

Low back pain in the last 48 hours assessed on a numerical pain scale (0 - 100) at 4 months

Secondary Outcomes

  • Quality of life (SF-12)(at 1 and 4 months)
  • Disability (Quebec questionnaire)(1 month and 4 months)
  • Anxiety and depression (HAD)(1 month and 4 months)
  • Overall serum antioxidant defenses(at inclusion (baseline) and 1 month after inclusion)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials